Scarica l'app Stockscreener
0.3305
7.94%
-0.0285
Dopo l'orario di chiusura:
.33
-0.0005
-0.15%
Precedente Chiudi:
$0.359
Aprire:
$0.356
Volume 24 ore:
854.84K
Relative Volume:
0.20
Capitalizzazione di mercato:
$10.84M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-19.43%
1M Prestazione:
-44.46%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.3111
$0.356
Intervallo di 1 settimana:
$0.3111
$0.4299
Portata 52W:
$0.3111
$2.22
Profusa Inc Stock (PFSA) Company Profile
Nome
Profusa Inc
Settore
Industria
Telefono
212-494-9022
Indirizzo
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Confronta PFSA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3305 | 12.79M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Profusa Inc Borsa (PFSA) Ultime notizie
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa Approves $100 Million Equity Line of Credit - TipRanks
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Profusa Restructures Securities Agreement for Flexibility - MSN
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Profusa Appoints New CFO and Lead Director - TipRanks
Profusa, Inc. shares fall 8.88% intraday despite adding seasoned finance executive Fred Knechtel as CFO. - AInvest
Profusa adds former VA chief and Fortune 500 executive to leadership - Investing.com
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO - The Manila Times
Profusa Welcomes Former Acting U.S. Veterans Affairs - GlobeNewswire
Profusa, Inc. Appoints Fred Knechtel as CFO - MarketScreener
Profusa, Inc. shares rise 4.26% premarket after announcing a distributor for its tissue oxygen technology. - AInvest
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform - MarketScreener
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa, Inc. SEC 10-Q Report - TradingView
Profusa Announces Nasdaq Listing and Growth Plans - TipRanks
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang - AlphaStreet
Profusa shares strategy update as it transitions to public company By Investing.com - Investing.com South Africa
Profusa shares strategy update as it transitions to public company - Investing.com India
Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
Profusa Achieves Milestones, Commits to Groundbreaking Biochemistry Tech. - AInvest
Profusa, Inc. Provides Strategy Overview and Business Update for Investors - Bluefield Daily Telegraph
Profusa Reports Q1 2026 Commercial Launch in Europe for Tissue Oxygen Monitoring Platform - AInvest
Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News - Stock Titan
Profusa, Inc. Secures Lumee?? Oxygen Platform Distributor in Spain - MarketScreener
Profusa signs LOI for distribution of Lumee Oxygen platform in Spain - Investing.com Australia
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain - The Manila Times
Profusa Signs Letter of Intent for Lumee Oxygen Distribution in Spain. - AInvest
Profusa Targets 300,000 Annual European Procedures with Spanish Distribution Partnership - Stock Titan
Profusa stock falls after announcing $1 million Bitcoin investment By Investing.com - Investing.com South Africa
Profusa invests $1 million in bitcoin as part of treasury strategy By Investing.com - Investing.com Nigeria
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy - The Manila Times
Profusa makes $1 million bitcoin investment as part of treasury strategy By Investing.com - Investing.com South Africa
Profusa Inc Azioni (PFSA) Dati Finanziari
Non sono disponibili dati finanziari per Profusa Inc (PFSA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):